US Pharma MarketingThe 25 highest-paid CEOs in biopharma for 2025 with $25M+ paydays
For the first time in four years, Endpoints News is raising the bar for what it means to be a top-paid CEO. The previous floor of $20 million is no ... Topic Hubs AI drug discovery: News, analysis and interviews Antibody-drug conjugates: The next wave of targeted cancer drugs Biopharma M&A and dealmaking: Who’s buying and why Biopharma people moves: CEO changes, executive hires, board positions Biotech IPOs: Tracking the market for new public offerings Biotech venture funding: Who’s raising and where the money is going Cell and gene therapy manufacturing: Scaling the next frontier China biotech: Licensing deals and…
For the first time in four years, Endpoints News is raising the bar for what it means to be a top-paid CEO.
The previous floor of $20 million is no longer rich enough. The biopharma ...
Source: Endpoints News